Congleton Jon 4
4 · IMMUNIC, INC. · Filed Jun 29, 2026
Research Summary
AI-generated summary of this filing
IMMUNIC (IMUX) Director Jon Congleton Receives 50,740-Share Option Award
What Happened
- Jon Congleton, a director of IMMUNIC, Inc. (IMUX), received a grant of options covering 50,740 shares on June 29, 2026. The reported acquisition price is $0.00 because this is a derivative award (options), not a cash purchase or sale. The grant was conditionally approved by the board on March 27, 2026 and became effective after stockholder approval on June 29, 2026.
Key Details
- Transaction date: 2026-06-29; reported acquisition price: $0.00 (derivative grant).
- Grant size: options to purchase 50,740 shares of common stock.
- Vesting: options vest in 36 equal monthly installments beginning March 27, 2026 (monthly vesting over three years). (See footnotes F1 & F2.)
- Share ownership after transaction: not specified in the provided filing extract.
- Filing timeliness: report filed with period and filing date 2026-06-29 (no late filing indicated).
Context
- This filing documents an equity compensation grant (options), not an exercise or sale. Such awards are commonly used for director compensation and do not represent an immediate cash transaction or market sale of shares. The options only become exercisable as they vest per the monthly schedule; the filing does not indicate any immediate sale or cashless exercise.
Insider Transaction Report
Form 4
IMMUNIC, INC.IMUX
Congleton Jon
Director
Transactions
- Award
Stock Option
[F1][F2]2026-06-29+50,740→ 50,740 totalExercise: $10.90Exp: 2036-03-27→ Common Stock (50,740 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock conditionally approved by the Board of Directors on March 27, 2026, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026.
- [F2]The options vest in thirty-six (36) equal installments on each monthly anniversary of March 27, 2026.
Signature
/s/ Grant Levine, attorney-in-fact|2026-06-29